Spectral karyotyping (SKY) refinement of a complex karyotype with t(20;21) in a Ph-positive CML patient submitted to peripheral blood stem cell transplantation

Bone Marrow Transplantation

Volumn 26, Issue 10, 2000, Pages 1125-1127

  Calabrese, G ^a,b   Fantasia, D ^a,b   Franchi, P G ^a,b   Morizio, E ^a,b   Stuppia, L ^a   Gatta, V ^a   Olioso, P ^c   Mingarelli, R ^d   Spadano, A ^e   Palka, G ^a,b  

^a UNIVERSITY OF CHIETI   (Italy)

^b Servizio di Genetica Umana   (Italy)

^c Centro Trapianti Midollo Osseo   (Italy)

^d Istituto Mendel   (Italy)

^e Ospedale Civile di Pescara   (Italy)

Author keywords

Chimeric gene; FISH; Philadelphia chromosome; SKY

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CYCLOSPORIN A; CYTARABINE; FLUDARABINE; HLA ANTIGEN; HYDROXYUREA; MITOXANTRONE; PROTEIN TYROSINE KINASE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BLAST CELL CRISIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; CHROMOSOME 20Q; CHROMOSOME 21Q; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 20; CHROMOSOME TRANSLOCATION 21; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; DRUG MEGADOSE; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; KARYOTYPING; LEUKEMOGENESIS; MALE; PERIPHERAL BLOOD STEM CELL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; SPECTROSCOPY; XENOTRANSPLANTATION;

EID: 0033693142     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702666     Document Type: Article

References (21)

1. Cellular and molecular mechanisms in chronic myeloid leukaemia: Biology and treatment
2. The molecular biology of chronic myeloid leukemia
3. Cell biology of CML cells
4. Non-random karyotypic evolution in chronic myeloid leukemia
5. Emergence of unusual cytogenetic abnormalities under interferon-alpha therapy in patients with chronic myelogenous leukemia
6. Aberrant cytogenetic evolution pattern of Philadelphia-positive chronic myeloid leukemia treated with interferon-alpha
7. Translocation (3;21)(q22;q22) in therapy-related myelodysplasia following drugs targeting DNA-topoisomerase II combined with alkylating agents, and in myeloproliferative disorders undergoing spontaneous leukemic transformation
8. Karyotypic evolution in Ph-positive chronic myeloid leukemia in relation to management and disease progression
9. Cytogenetics in patients with chronic myelogenous leukemia treated with bone marrow transplantation
10. Multicolor spectral karyotyping of human chromosomes
11. Chromosome mapping of the human arrestin (SHG), β-arrestin 2 (ARRB2), and β-adrenergic receptor kinase 2 (ADRBK2) genes
12. Quantitative acute leukemia cytogenetics
13. Is cancer cytogenetics reducible to the molecular genetics of cancer cells?
14. Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene
15. Fluorescence in situ hybridization analysis of chromosome 1 abnormalities in hematopoietic disorders: Rearrangements of DNA satellite II and new recurrent translocations
16. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia
17. The role of chromosome translocations in leukemogenesis
18. The dominating effect of mutant p53
19. The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion